Drägerwerk AG & Co. KGaA Reports Strong Q1 2026 Financial Results
Drägerwerk AG & Co. KGaA reported strong Q1 2026 results, with order intake up over 3%, net sales growth of ~7%, and a significant jump in group EBIT to EUR 17.9m. The safety division drove profitability with 9% sales growth and an EBIT margin of ~11%, while the medical division showed improved performance. Management proposed a higher dividend and reiterated full-year guidance.
Topics: Dividend Increase Earnings EBIT Margin Medical Division Order Intake Revenue Growth Safety Division